Category Archives: Pharmacogenomics

This report studies the Sports and Fitness Genomics and Pharmacogenomics Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Sports and Fitness Genomics and Pharmacogenomics Market analysis segmented by companies, region, type and applications in the report.

The report offers valuable insight into the Sports and Fitness Genomics and Pharmacogenomics market progress and approaches related to the Sports and Fitness Genomics and Pharmacogenomics market with an analysis of each region. The report goes on to talk about the dominant aspects of the market and examine each segment.

Key Players: GeneDx, Assurex Health, 23andMe, Teva Pharmaceutical Industries, Future Science Group, Myriad Genetics, Pathway Genomics, and GeneTech

The final report will add the analysis of the Impact of Covid-19 in this report Sports and Fitness Genomics and Pharmacogenomics industry.

Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-sports-and-fitness-genomics-and-pharmacogenomics-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?utm_source=neighborwebsj&utm_medium=36

The global Sports and Fitness Genomics and Pharmacogenomics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sports and Fitness Genomics and Pharmacogenomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2020-2026.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Sports and Fitness Genomics and Pharmacogenomics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Sports and Fitness Genomics and Pharmacogenomics market by identifying its various sub segments.

Focuses on the key global Sports and Fitness Genomics and Pharmacogenomics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Sports and Fitness Genomics and Pharmacogenomics with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Sports and Fitness Genomics and Pharmacogenomics submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

Table of Contents: Sports and Fitness Genomics and Pharmacogenomics Market

Chapter 1: Overview of Sports and Fitness Genomics and Pharmacogenomics Market

Chapter 2: Global Market Status and Forecast by Regions

Chapter 3: Global Market Status and Forecast by Types

Chapter 4: Global Market Status and Forecast by Downstream Industry

Chapter 5: Market Driving Factor Analysis

Chapter 6: Market Competition Status by Major Manufacturers

Chapter 7: Major Manufacturers Introduction and Market Data

Chapter 8: Upstream and Downstream Market Analysis

Chapter 9: Cost and Gross Margin Analysis

Chapter 10: Marketing Status Analysis

Chapter 11: Market Report Conclusion

Chapter 12: Research Methodology and Reference

Key questions answered in this report

What will the market size be in 2026 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Get complete Report @ https://www.reportsandmarkets.com/sample-request/global-sports-and-fitness-genomics-and-pharmacogenomics-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?utm_source=neighborwebsj&utm_medium=36

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

https://neighborwebsj.com/

See the article here:
Sports and Fitness Genomics and Pharmacogenomics Market Size And Forecast (2020-2026)| With Post Impact Of Covid-19 By Top Leading Players- GeneDx,...

Global Molecular Diagnostics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Increasing number of chronic & infectious diseases and technological advancements are key drivers for Global Molecular Diagnostics Market.

In its latest report on Molecular Diagnostics Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players.

The term molecular diagnostics refers to clinical tests used to identify a disease or the susceptibility to a disease, by analyzing DNA / RNA or their proteins, in humans or in the case of infections, in microbes. Its scope includes the clinical testing devices, as well as their reagents and supplies that are utilized in hospitals, clinics, commercial laboratories, reference laboratories and research institutes to detect cells and proteins for the purpose of diagnosis and monitoring disease. Molecular diagnostics play an important role in infectious disease testing as they provide effective and fast results. So, during the study of Global Molecular Diagnostics Market, we have considered global molecular diagnostics products and consumables to analyze the market.

Get Sample Copy of The Report@https://brandessenceresearch.com/requestSample/PostId/242

Global molecular diagnostics market report is segmented on the basis of product, technology, application and end user. Based on product global molecular diagnostics market is classified as instruments, reagents and services. Based upon technology, global molecular diagnostics market is classified as PCR (Polymerase Chain Reaction), INAAT (Isothermal Nucleic Acid Amplification Technology), DNA sequencing, hybridization, microarray and others. Based upon applications, global molecular diagnostics market is classified as infectious diseases, chronic diseases, genetic testing, screening and pharmacogenomics. Based upon end user type, global molecular diagnostics market is classified as hospitals, laboratories and research institutes.

The regions covered in this global molecular diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Global Molecular Diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Global molecular diagnostics market report covers prominent play Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare GmbH, Alere, Inc., Dako, Bayer AG, Hologic, Inc., Danaher, Sysmex Corporation, Novartis AG, Johnson & Johnson, Qiagen N.V., Becton Dickinson and Company, Roche Diagnostics, BioMerieux SA, Cepheid, Quidel Corporation, Debiopharm Group, Onkogen Diagnostik Sistemler Ltd., Myriad Genetics, Genomic Health, Luminex, GenMark Diagnostics, Biocartis Group and others.

Increasing number of chronic diseases such as cancer, cardiovascular disease, diabetes, pulmonary respiratory diseases, arthritis have led to the growth of the molecular diagnostics market. Moreover, rise in awareness among people, demand for early diagnostics of diseases, improving healthcare facilities and technological advancements are majorly responsible for the continuous growth of the molecular diagnostics market. According to World Health Organization, infectious diseases kill over 17 million people a year. However, high costs and regulatory hurdles in approval process are the major restrains of the Global Molecular Diagnostics Market. Nonetheless, untapped market and technological advancements may generate new opportunities in forecast period.

North America dominates the market with highest market share due to increase in funding by governments and different organizations, rise in number of cases of infectious and chronic diseases and increase in awareness of personalized medicines. In U.S, every year, around 1.7 million Hospital Acquired Infections (HAIs) are encountered, resulting in 99,000 deaths and costing an estimated USD 20 billion. Availability of robust healthcare infrastructure in this region has boosted the demand for molecular diagnostics

Europe is the second largest market for global molecular diagnostics. Increasing prevalence of chronic diseases, increasing healthcare expenditure, growing awareness among people, extensive research and development activities are majorly responsible on growth of Global Molecular Diagnostics Market in Europe. According to National Statistics, total current healthcare expenditure of UK in 2016 was around 253.9 billion USD. The rising demand for point-of-care and rapid testing, primarily blood glucose testing, and the strong government support to promote early disease detection to prevent ill-health are some of the major factors driving the molecular diagnostics market in UK.

Asia Pacific region is showing robust growth in Global Molecular Diagnostics Market due to increasing population, rising disposable income among the population, high incidences of chronic diseases and infectious diseases and improving healthcare infrastructure. Non-communicable diseases (NCDs) are the critical cause of disease burden and mortality in the Asia Pacific region, claiming 55% of total life in the South East Asia region each year and 75% in the Western Pacific region.

Get Methodology of Report @https://brandessenceresearch.com/requestMethodology/PostId/242

By Product

By Technology

By Application

By End User

By Region

Get Full Report :@https://brandessenceresearch.com/healthcaremolecular-diagnostics-market

Related Report:@

https://www.marketwatch.com/press-release/us-residential-gas-generator-market-by-trends-key-players-driver-segmentation-forecast-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/us-protein-chip-market-size-industry-research-on-growth-trends-opportunity-and-top-companies-analysis-in-2021-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/europe-overactive-bladder-treatment-market-analysis-by-industry-growth-size-share-demand-trends-and-latest-research-report-2021-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/us-portable-ultrasound-devices-market-share-current-trends-and-research-development-report-to-2027-covid-19-impact-analysis-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/organoid-kit-market-size-global-industry-analysis-and-opportunity-assessment-2021-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/global-nutraceutical-products-market-size-industry-research-on-growth-trends-opportunity-and-forecast-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/non-oriented-electrical-steel-market-2021-global-size-industry-share-outlook-trends-geographical-segmentation-business-challenges-and-opportunity-analysis-till-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/us-near-infrared-spectroscopy-market-size-2021-growing-demand-for -nirs-industry-analysis-growth-regional-revenue-top-company-profiles-cagr-values-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/europe-muscle-relaxant-drugs-market-industry-analysis-size-share-growth-trends-and-forecast-20212027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/us-sexually-transmitted-diseases-testing-market-size-share-growing-demand-for-std-testing-industry-analysis-report-by-trends-covid-19-impact-top-players-are-orasure-affymetrix-diasorin-biomerieux-hologic-inc-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/global-silicon-electrical-steel-market-2021-industry-analysis-size-share-trends-segmentation-and-forecast-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/emerging-growth-for-smart-inhalers-market-by-2021-2027-top-players-are-astrazeneca-plc-propeller-health-opko-health-adherium-limited-novartis-ag-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/uk-sms-firewall-market-size-share-advanced-technologies-with-application-analysis-regional-outlook-growth-trends-key-players-and-competitive-strategies-forecast-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/software-defined-anything-sdx-market-size-share-application-analysis-regional-outlook-growth-trends-key-players-and-competitive-strategies-forecast-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/europe-soundproof-curtains-market-2021-industry-research-share-trend-europe-industry-size-price-future-analysis-regional-outlook-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/europe-sports-headphones-market-2021-industry-research-share-trend-europe-industry-size-price-future-analysis-regional-outlook-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/us-sports-optic-market-report-2021-by-product-services-technology-share-trend-us-industry-size-price-future-analysis-regional-outlook-to-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/uk-sports-wheelchair-market-2021-top-companies-analysis-share-latest-trend-uk-industry-size-price-demand-regional-outlook-and-industry-report-2027-2021-02-08?tesla=y

https://www.marketwatch.com/press-release/us-air-freshener-market-share-industry-sales-supply-demand-consumption-analysis-market-size-and-regional-outlook-to-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/anti-pollution-face-mask-market-size-share-industry-analysis-report-by-trends-covid-19-impact-top-players-are-brand-x-honeywell-idmask-lifeline-maskin-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/us-3d-printed-drugs-market-size-industry-analysis-and-opportunity-assessment-2021-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/3d-bioprinting-market-growing-at-a-cagr-of-3125-market-size-share-current-trends-and-research-development-report-to-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/us-infusion-pump-market-share-2021-analysis-by-industry-growth-size-demand-trends-and-research-overview-report-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/injector-nozzle-market-size-worth-720646-million-industry-trends-key-players-driver-segmentation-forecast-by-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/uk-leather-jacket-market-share-industry-sales-supply-demand-consumption-analysis-market-size-and-regional-outlook-to-2027-schott-nyc-san-diego-legendary-usa-jkm-leathers-oasis-jackets-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/lithotripsy-devices-market-expected-to-reach-usd-189693-million-share-current-trends-and-research-development-report-to-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/us-mhealth-market-report-analysis-2021-growing-demand-for-mhealth-industry-growth-regional-revenue-top-company-profiles-cagr-values-and-research-development-report-to-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/europe-mosquito-repellent-market-size-industry-research-on-growth-trends-opportunity-and-top-companies-analysis-in-2021-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/us-nebulizer-market-size-share-industry-analysis-report-by-trends-covid-19-impact-top-players-are-devillbiss-healthcare-ge-healthcare-becton-dickinson-philips-healthcare-omron-healthcare-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/at-4797-cagr-network-automation-market-size-set-to-register-8177-billion-usd-by-2026-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/us-off-road-electric-vehicles-market-industry-overview-2021-top-companies-analysis-share-current-trends-segmentation-gm-john-deere-ford-mitsubishi-fiat-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/us-radiology-information-systems-market-share-current-trends-and-research-development-report-to-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/toilet-and-toilet-accessories-market-2021-top-key-players-are-bemis-geberit-toshiba-roca-pressalit-seats-toto-and-forecast-to-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/traveling-bags-market-2021-global-industry-sales-supply-demand-consumption-analysis-and-forecasts-to-2027-2021-02-05?tesla=y

https://www.marketwatch.com/press-release/us-digital-weight-measuring-machine-market-2021-share-size-trends-industry-growth-and-forecast-by-2027-2021-02-05?tesla=y

Read the original post:
Molecular Diagnostics Market by Services, Technology, Overview, Component, Industry Revenue, Cost Structure Analysis and Forecast to 2027 KSU | The...

Southern Arizona 2021 Heart Ball Co-chairs Joseph Alpert, M.D. and Qin Chen, PhD., and other supporters hope to raise at least $50,000 at the digital experience (tucsonheartball.heart.org), which is free and open to the public at 6 p.m. on Saturday, Feb. 13.

By Loni NanniniSpecial to the Arizona Daily Star

The American Heart Association is giving a ball and you dont need a tux or a gown or even an invitation to attend.

The Southern Arizona 2021 Heart Ball has gone digital and for the first time ever, it is open to the community for free online at tucsonheartball.heart.org at 6 p.m. Saturday, Feb. 13.

Human beings are pack animals ... we love being together in groups. We will miss seeing folks face-to-face, but with the pandemic, that is not happening this year, said Dr. Joseph Alpert, co-chair of the event with his wife, Qin Chen. This digital event does present an opportunity for people around the country whether they are in Alaska or Portland, Maine to hear about all that the American Heart Association is doing and to participate in the online auction, so we are hoping people outside of Tucson will get involved. Hopefully this will help bring folks together across the country.

The couple are long-time supporters of the association, according to Alpert, a professor of medicine at the University of Arizona Sarver Heart Center. He and Chen, the director of pharmacogenomics and professor of pharmacology at the UA who also performs cardiac research, received grant funding from the association for research early in their careers.

The associations grants often serve as seed funding to enable researchers to qualify for larger grants from the National Institutes of Health and other organizations, said Krystal Webb, communications director for the heart association in Tucson.

Continued here:
Arizona Heart Association's 2021 Heart Ball is digital event this year - Arizona Daily Star

The pharmacogenomics report published by Data Bridge Market research is the representation of data and analysis of the market. It gives detailed analysis of the current market scenario and a market forecast till 2026. The data included in this pharmacogenomics report provides detailed information of the geographic landscape, competitive scenarios and upcoming opportunities in the Industry. The inclusion of the statistical records in the pharmacogenomics report helps in authenticating the results that are being presented and thus provide a clear vision and indication to clients in understanding the response of the participants.

Global pharmacogenomics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pharmacogenomics-market&kb

The major players covered in the global pharmacogenomics market are Abbott, AstraZeneca, Bayer AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, OPKO Health, Inc, Teva Pharmaceutical Industries Ltd, Myriad Genetics, Inc., QIAGEN,OneOme, LLC, Illumina, Inc, Empire Genomics, LLC, and Dynamic DNA Laboratories among others.

Global Pharmacogenomics Market Scope and Market Size

Pharmacogenomics market is segmented on the basis of technology, application, end-users and distribution channel.

Patient Epidemiology Analysis

Pharmacogenomics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Enquire Here Get customization & check discount for report @: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pharmacogenomics-market&kb

Pharmacogenomics Market Country Level Analysis

Pharmacogenomics market is analysed and market size information is provided by country, technology, application, end-users and distribution channel as referenced above.

The countries covered in the global pharmacogenomics market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America has been witnessing a positive growth throughout the forecasted period due to the presence of refined healthcare expenditure and increased patient awareness level as well as preference personalized medicines. Europe is considered a second largest growing regional segment owing to the growing geriatric population and rising prevalence of chronic diseases.

Points Involved in pharmacogenomics Market Report:

Get Detailed Table Of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-pharmacogenomics-market&kb

Insights of the Study

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. GetCustomizationandDiscounton Report by emailingsopan.gedam@databridgemarketresearch.com. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market ResearchUS: +1 888 387 2818UK: +44 208 089 1725Hong Kong: +852 8192 7475Email: Corporatesales@databridgemarketresearch.com

Go here to see the original:
Global Pharmacogenomics Market To Witness An Outstanding Growth By 2027||Thermo Fisher Scientific Inc, OPKO Health, Inc, Teva Pharmaceutical...

The major driving factors for the growth of this market in the North American region is the rising demand for personalized medicines, high medical reimbursement facilities, and technological advancement.

The Pharmacogenomics market analysis report ismainly focused on leading market players. Our analysts have provided information on financial statements of these players, product benchmarking, and their key business development strategies.

Claim Your FREE Sample Copy with Table of [emailprotected] https://www.emergenresearch.com/request-sample-form/88

Key participants include Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory Corporation of America Holdings, among others.

Pharmacogenomics Market Overview:

The latest market study broadly segments the industry based on the product type range, application gamut, end-use industry, key regions, and the competitive background. One of the central components of the report is a detailed explanation of the gross profits, revenue shares, sales volume, manufacturing costs, individual growth rate, and the financial standing of the leading market players. The developmental scope of the Pharmacogenomics markets new entrants and established companies has also been emphasized in the report.

Check Our [emailprotected]https://www.emergenresearch.com/select-license/88

Product and Services Outlook (Revenue, USD Billion; 2017-2027)

Products

Kits

Assays and Reagents

Instruments

Software

Services

Genotyping

SNP Identification

Pharmacogenetic Testing

Other Services

Technology Outlook (Revenue, USD Billion; 2017-2027)

Polymerase Chain Reaction (PCR)

Real-Time PCR

qPCR

Digital PCR

DNA Sequencing/Next Generation Sequencing (NGS)

Nucleic Acid Amplification Tests (NAATs)

Mass Spectrometry

Gel Electrophoresis

Hybridization

Fluorescence In Situ Hybridization (FISH)

Chromogenic In Situ Hybridization (CISH)

Others

Microarray

Others

Application Outlook (Revenue, USD Billion; 2017-2027)

Oncology

Infectious Diseases

Neurology/Psychiatry

Cardiovascular

Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

Research Organization

Pharmaceutical Companies

Diagnostic Centers

Others

In market segmentation by geographical regions, the report has analysed the following regions-

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Columbia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Click to access the Report Study, Read key highlights of the Report and Look at Projected [emailprotected] https://www.emergenresearch.com/industry-report/pharmacogenomics-market

Table of ContentChapter 1. Methodology & Sources1.1. Pharmacogenomics Market Definition1.2. Research Scope1.3. Methodology1.4. Research Sources1.4.1. Primary1.4.2. Secondary1.4.3. Paid Sources1.5. Pharmacogenomics Market Estimation TechniqueChapter 2. Executive Summary2.1. Pharmacogenomics Market Summary Snapshot, 2021-2028Chapter 3. Pharmacogenomics Market Key InsightsChapter 4.Pharmacogenomics Market Segmentation & Impact Analysis4.1.Pharmacogenomics Market Segmentation Analysis4.2. Pharmacogenomics Industrial Outlook4.2.1. Market indicators analysis4.2.2. Pharmacogenomics Market drivers analysis4.2.3. Pharmacogenomics Market restraints analysis4.3. Technological Insights4.4. Regulatory Framework4.5. Porters Five Forces Analysis4.6. Competitive Metric Space Analysis4.7. Price trend Analysis4.8. Covid-19 Impact Analysis

Click to access the Complete Pharmacogenomics Market ReportTable of Content: https://www.emergenresearch.com/industry-report/pharmacogenomics-market

Thank you for reading our report. Customization of the report is available as per client requirements. Kindly get in touch with us to know more about the report.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Explore our related report from different Publications:

Smart Irrigation Controllers MarketTo Be Worth USD 732.7 Million by 2027 Growing at a CAGR of 14.9% | Emergen Research

Soldier System Marketto Reach USD 15.19 Billion By 2027 Growing at a CAGR of 4.8% | Emergen Research

Plant-Based Food & Beverage Alternatives Marketto Reach USD 32.29 Billion By 2027 | Emergen Research

Nano Drones Marketto Reach USD 4.04 Billion By 2027 Growing at a CAGR of 26.8% | Emergen Research

Fermented Food and Ingredients MarketTo Be Worth USD 875.21 Billion by 2027 | Emergen Research

Signal Intelligence (SIGINT) Marketto Reach USD 18.28 Billion By 2027 | Emergen Research

Sodium Dichromate MarketTo Be Worth USD 1,242.4 Million by 2027| Emergen Research

Industrial Microbiology MarketTo Be Worth USD 17.71 Billion by 2027| Emergen Research

Surgical Instrument Tracking Systems MarketTo Reach USD 431.6 Million by 2027| Emergen Research

Medical Lighting Technologies MarketSize To Be Worth USD 2.99 Billion by 2027 | Emergen Research

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail:[emailprotected]

Facebook|LinkedIn|Twitter|Blogs

Continued here:
Pharmacogenomics Market Growth, Competitive Landscape, Research Methodology, Business Opportunities, Statistics and Industry Analysis Report by 2027 ...

COVINGTON, Ky., Jan. 28, 2021 /PRNewswire/ -- On Tuesday, January 26th, Governor Andy Beshear's office announced that the first two cases of a more contagious variant of coronavirus, first identified in the United Kingdom, have been confirmed in Kentucky. Local Covington-based Gravity Diagnostics began coordinating with the Kentucky Department of Health weeks ago to submit specimens with a unique detection pattern for sequence analysis. This led to the discovery announced on Tuesday by Beshear's office. Dr. Steven Stack, commissioner for public health for the Commonwealth of Kentucky, thanked the laboratory during the Governor's press conferenceWednesday afternoon.

Background from Gravity Diagnostics on detection of SARS-CoV-2 emerging variants Gravity Diagnostics utilizes a molecular test for the detection of SARS-CoV-2. Our test relies on specific RNA sequences for the identification of the virus in clinical specimens. However, RNA viruses, such as SARS-CoV-2, mutate resulting in changes to their RNA sequence. One specific mutation in the S-gene is associated with an increased risk of transmission, the B.1.1.7 variant. This variant contains a deletion in the S-gene which can impact the detection of SARS-CoV-2 with molecular tests.

Impact on Gravity Diagnostics SARS-CoV-2 RT-PCR Assay (EUA202301) Gravity Diagnostics utilizes a modification of the ThermoFisher TaqPath COVID-19 Combo Kit for our SARS-CoV-2 testing. Their methodology detects three distinct genes (S-gene, N-gene, ORF1ab) in the SARS-CoV-2 viral genome, which offers a built-in redundancy for detection of the virus. They have become aware that certain variants will not have the S-gene amplify, but the other two targets will detect the SARS-CoV-2 virus. Analysis by the FDA suggests no impact to the overall sensitivity of the assay. In fact, they can use this pattern of detection to possibly track new variant spread. Once this was known, they began to coordinate with the Kentucky Department of Public Health to submit specimens with this detection pattern for sequence analysis. This information will be used to prepare public health officials with contact tracing and potentially prevent further spread of infection.

"I reached out to our Director of Research and Development, Ryan Walker, PhD., in late December to begin research on how we could start testing for and tracking the SARS-CoV-2 variants. At Gravity part of our core mission is always to go beyond testing samples and reporting results to being a part of a larger, more comprehensive solution that makes a positive impact on and protects our community. With the pandemic, one way we are doing that is by providing more information to the experts who are tracking and coordinating efforts in the field, not just the baseline 'positive and negative' test results. This recent assistance in the discovery of the first two variants of the U.K. strand is a testament to the dedication and expertise of our clinical team. I could not be prouder and we will continue to expand and support these efforts," said Julie Brazil, chief operating officer at Gravity Diagnostics.

About Gravity Diagnostics Gravity Diagnostics is a full-service state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing in the areas of COVID-19, Upper Respiratory, Toxicology, Pharmacogenomics, and Sexually Transmitted Infections. We are an advocate for physicians, patients, and our communities, supporting them with unsurpassed integrity, regulatory compliance, and clinical expertise. We currently service over 750 customers from small private practices, to universities, to Fortune 500 companies. Media contact: [emailprotected]. For more information, visit http://www.gravitydiagnostics.com.

SOURCE Gravity Diagnostics

Home

Original post:
Gravity Diagnostics Coordination with Kentucky Department of Health Leads to Findings of First Cases of UK COVID-19 Variant Identified in the State -...